Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelination
Abstract One of the therapeutic approaches for the treatment of the autoimmune demyelinating disease, multiple sclerosis (MS) is bone marrow mesenchymal stromal cell (hBM-MSCs) transplantation. However, given their capacity to enhance myelination in vitro, we hypothesised that human olfactory mucosa...
Main Authors: | Susan L. Lindsay, Aleksandra M. Molęda, Lindsay M. MacLellan, Siew Min Keh, Daniel E. McElroy, Christopher Linington, Carl S. Goodyear, Susan C. Barnett |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-022-01316-9 |
Similar Items
-
Development of Good Manufacturing Practice-Compatible Isolation and Culture Methods for Human Olfactory Mucosa-Derived Mesenchymal Stromal Cells
by: Christopher J. Kelly, et al.
Published: (2024-01-01) -
Myelin oligodendrocyte glycoprotein encephalomyelitis: An unusual cause of blindness
by: Nimrat Sandhu, et al.
Published: (2022-01-01) -
Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01) -
Recurrent myelin oligodendrocyte glycoprotein⁃IgG⁃associated optic neuritis⁃encephalomyelitis: one case report
by: Jing SHA, et al.
Published: (2020-10-01) -
Effects of Olfactory Mucosa Stem/Stromal Cell and Olfactory Ensheating Cells Secretome on Peripheral Nerve Regeneration
by: Rui D. Alvites, et al.
Published: (2022-06-01)